[Primitive neuroectodermal tumor in female genital tract: a clinicopathologic study]

Zhonghua Bing Li Xue Za Zhi. 2012 Nov;41(11):729-32. doi: 10.3760/cma.j.issn.0529-5807.2012.11.004.
[Article in Chinese]

Abstract

Objective: To study the clinicopathologic features of primitive neuroectodermal tumor (PNET) in female genital tract.

Methods: Six cases of PNET arising in female genital tract were retrospectively reviewed. The clinicopathologic features, immunohistochemical findings and EWS gene translocation study results were analyzed.

Results: The age of patients ranged from 10 to 27 years (mean = 20 years). The sites of involvement included ovary (1 case), uterus (1 case), vulva (2 cases) and vagina (2 cases). The greatest diameter of the tumor ranged from 2 to 10 cm (mean = 5.4 cm). The tumor had nodular appearance and showed grayish-pink fleshy cut surface, accompanied by foci of hemorrhage and necrosis. Histologically, the tumor was composed of malignant small round cells with indistinct cell borders, hyperchromatic nuclei, dense chromatin, tiny nucleoli and scanty cytoplasm. The tumor cells were arranged in sheets or lobules. Homer-Wright rosettes were identified in 1 case. Immunohistochemical study showed that the tumor cells were positive for CD99, FLI-1 and CD56 (6/6). Focal expression of vimentin (5/6), NSE (5/6), nestin (4/6), synaptophysin (4/6), S-100 protein (2/6) and chromogranin A (1/6) was also demonstrated. EWS gene translocation was detected in 5 cases studied. Follow-up information was available in 2 patients (7 and 17 months of follow up, respectively). One of them died of tumor metastasis 17 months after diagnosis. The other patient was still alive.

Conclusions: PNET arising in female genital tract is rare. It mainly involves ovary, uterus, vulva and vagina. Immunohistochemical study using a panel of antibodies and fluorescence in-situ hybridization play an important role in definitive diagnosis of this rare malignancy.

MeSH terms

  • 12E7 Antigen
  • Adolescent
  • Adult
  • Antigens, CD / metabolism
  • CD56 Antigen / metabolism
  • Cell Adhesion Molecules / metabolism
  • Child
  • Female
  • Follow-Up Studies
  • Genital Neoplasms, Female / genetics
  • Genital Neoplasms, Female / metabolism
  • Genital Neoplasms, Female / pathology*
  • Genital Neoplasms, Female / surgery
  • Humans
  • Neuroectodermal Tumors, Primitive, Peripheral / genetics
  • Neuroectodermal Tumors, Primitive, Peripheral / metabolism
  • Neuroectodermal Tumors, Primitive, Peripheral / pathology*
  • Neuroectodermal Tumors, Primitive, Peripheral / surgery
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / metabolism
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / surgery
  • Proto-Oncogene Protein c-fli-1 / metabolism
  • RNA-Binding Protein EWS / genetics
  • Retrospective Studies
  • Translocation, Genetic
  • Uterine Neoplasms / genetics
  • Uterine Neoplasms / metabolism
  • Uterine Neoplasms / pathology
  • Uterine Neoplasms / surgery
  • Vaginal Neoplasms / genetics
  • Vaginal Neoplasms / metabolism
  • Vaginal Neoplasms / pathology
  • Vaginal Neoplasms / surgery
  • Vimentin / metabolism
  • Vulvar Neoplasms / genetics
  • Vulvar Neoplasms / metabolism
  • Vulvar Neoplasms / pathology
  • Vulvar Neoplasms / surgery
  • Young Adult

Substances

  • 12E7 Antigen
  • Antigens, CD
  • CD56 Antigen
  • CD99 protein, human
  • Cell Adhesion Molecules
  • FLI1 protein, human
  • NCAM1 protein, human
  • Proto-Oncogene Protein c-fli-1
  • RNA-Binding Protein EWS
  • Vimentin